Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1995 Oct;50(10):1057–1061. doi: 10.1136/thx.50.10.1057

Exacerbations of asthma without sputum eosinophilia.

M O Turner 1, P Hussack 1, M R Sears 1, J Dolovich 1, F E Hargreave 1
PMCID: PMC475018  PMID: 7491553

Abstract

BACKGROUND--Sputum analysis provides a non-invasive method of examining the airway secretions of subjects with asthma in order to better understand the inflammatory process. Increased proportions of eosinophils are generally seen in the sputum of subjects with asthma, especially when there is an exacerbation. An unexpected observation in the sputum of subjects with mild exacerbations of asthma is reported. METHODS--Thirty four consecutive subjects with symptoms consistent with a mild exacerbation of asthma were recruited for a treatment study. Inclusion criteria required persistent symptoms of chest tightness, dyspnoea, or wheezing for two weeks (without spontaneous improvement or alteration in dose of inhaled corticosteroid) and a forced expiratory volume in one second (FEV1) that was reversible to more than 75% predicted or known best to ensure the exacerbation was mild. Sputum (spontaneous or induced with hypertonic saline) from all subjects was examined for differential cell counts. Eosinophilic sputum was defined as > or = 4% eosinophils on two occasions or > 10% eosinophils once. Clinical characteristics, sputum differential counts, and measurements of airways obstruction were compared between the subjects with and without sputum eosinophilia. RESULTS--Almost half of the subjects (16 of 34) considered to have mildly uncontrolled asthma had no sputum eosinophilia. In comparison with the subjects who had sputum eosinophilia the non-eosinophilic group had less airways obstruction (FEV1% predicted 88% v 70%) and less severe airways hyperresponsiveness (PC20 methacholine 0.45 mg/ml v 0.13 mg/ml). There was no difference between the groups in the type or prevalence of symptoms, history of recent infections, smoking, relevant allergen exposure, or use of inhaled corticosteroid. CONCLUSIONS--Symptoms of mildly uncontrolled asthma are not always associated with eosinophilic airways inflammation as measured by sputum analysis. The causes and treatment of the non-eosinophilic condition require further investigation.

Full text

PDF
1057

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelroth E., Hargreave F. E., Ramsdale E. H. Do physicians need objective measurements to diagnose asthma? Am Rev Respir Dis. 1986 Oct;134(4):704–707. doi: 10.1164/arrd.1986.134.4.704. [DOI] [PubMed] [Google Scholar]
  2. Bardin P. G., Johnston S. L., Pattemore P. K. Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms. Clin Exp Allergy. 1992 Sep;22(9):809–822. doi: 10.1111/j.1365-2222.1992.tb02825.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Crapo R. O., Morris A. H., Gardner R. M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981 Jun;123(6):659–664. doi: 10.1164/arrd.1981.123.6.659. [DOI] [PubMed] [Google Scholar]
  4. Fahy J. V., Kim K. W., Liu J., Boushey H. A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995 Apr;95(4):843–852. doi: 10.1016/s0091-6749(95)70128-1. [DOI] [PubMed] [Google Scholar]
  5. Fahy J. V., Liu J., Wong H., Boushey H. A. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol. 1994 Jun;93(6):1031–1039. doi: 10.1016/s0091-6749(94)70052-4. [DOI] [PubMed] [Google Scholar]
  6. Gibson P. G., Dolovich J., Denburg J., Ramsdale E. H., Hargreave F. E. Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1989 Jun 17;1(8651):1346–1348. doi: 10.1016/s0140-6736(89)92801-8. [DOI] [PubMed] [Google Scholar]
  7. Gibson P. G., Girgis-Gabardo A., Morris M. M., Mattoli S., Kay J. M., Dolovich J., Denburg J., Hargreave F. E. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax. 1989 Sep;44(9):693–699. doi: 10.1136/thx.44.9.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gibson P. G., Hargreave F. E., Girgis-Gabardo A., Morris M., Denburg J. A., Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy. 1995 Feb;25(2):127–132. doi: 10.1111/j.1365-2222.1995.tb01017.x. [DOI] [PubMed] [Google Scholar]
  9. Girgis-Gabardo A., Kanai N., Denburg J. A., Hargreave F. E., Jordana M., Dolovich J. Immunocytochemical detection of granulocyte-macrophage colony-stimulating factor and eosinophil cationic protein in sputum cells. J Allergy Clin Immunol. 1994 May;93(5):945–947. doi: 10.1016/0091-6749(94)90390-5. [DOI] [PubMed] [Google Scholar]
  10. Hargreave F. E., Popov T., Kidney J., Dolovich J. Sputum measurements to assess airway inflammation in asthma. Allergy. 1993;48(17 Suppl):81–86. doi: 10.1111/j.1398-9995.1993.tb04705.x. [DOI] [PubMed] [Google Scholar]
  11. Kendrick A. H., Higgs C. M., Whitfield M. J., Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993 Aug 14;307(6901):422–424. doi: 10.1136/bmj.307.6901.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maestrelli P., Calcagni P. G., Saetta M., Di Stefano A., Hosselet J. J., Santonastaso A., Fabbri L. M., Mapp C. E. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin Exp Allergy. 1994 Jan;24(1):29–34. doi: 10.1111/j.1365-2222.1994.tb00913.x. [DOI] [PubMed] [Google Scholar]
  13. Pin I., Freitag A. P., O'Byrne P. M., Girgis-Gabardo A., Watson R. M., Dolovich J., Denburg J. A., Hargreave F. E. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis. 1992 Jun;145(6):1265–1269. doi: 10.1164/ajrccm/145.6.1265. [DOI] [PubMed] [Google Scholar]
  14. Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25–29. doi: 10.1136/thx.47.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., Hargreave F. E. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy. 1994 Aug;24(8):778–783. doi: 10.1111/j.1365-2222.1994.tb00990.x. [DOI] [PubMed] [Google Scholar]
  16. Seltzer J., Bigby B. G., Stulbarg M., Holtzman M. J., Nadel J. A., Ueki I. F., Leikauf G. D., Goetzl E. J., Boushey H. A. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol (1985) 1986 Apr;60(4):1321–1326. doi: 10.1152/jappl.1986.60.4.1321. [DOI] [PubMed] [Google Scholar]
  17. Shim C. S., Williams M. H., Jr Evaluation of the severity of asthma: patients versus physicians. Am J Med. 1980 Jan;68(1):11–13. doi: 10.1016/0002-9343(80)90155-2. [DOI] [PubMed] [Google Scholar]
  18. Sur S., Crotty T. B., Kephart G. M., Hyma B. A., Colby T. V., Reed C. E., Hunt L. W., Gleich G. J. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993 Sep;148(3):713–719. doi: 10.1164/ajrccm/148.3.713. [DOI] [PubMed] [Google Scholar]
  19. Virchow J. C., Jr, Hölscher U., Virchow C., Sr Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis. 1992 Sep;146(3):604–606. doi: 10.1164/ajrccm/146.3.604. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES